 STUDY OF BENDAMUSTINE HYDROCHLORIDE AND RITUXIMAB BR COMPARED WITH R-CVP OR R-CHOP IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED INDOLENT NON-HODGKINS LYMPHOMA NHL OR MANTLE CELL LYMPHOMA MCL - REFERRED TO AS THE BRIGHT STUDY: 